Anticorpo monoclonal (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anticorpo monoclonal" in Galician language version.

refsWebsite

Global rank Galician rank

20nih.gov

4^th place

6^th place

12doi.org

2^nd place

7^th place

5web.archive.org

1^st place

3elsevier.com

610^th place

214^th place

2archive.org

6^th place

8^th place

1harvard.edu

18^th place

38^th place

1landesbioscience.com

low place

9,252^nd place

1archive.today

14^th place

30^th place

1cam.ac.uk

670^th place

532^nd place

1wikipedia.org

low place

1bloomberg.com

99^th place

506^th place

1amgen.com

low place

1regeneron.com

low place

1kymab.com

low place

1oup.com

485^th place

312^th place

1ukbusinesspark.co.uk

low place

1sciencedirect.com

149^th place

162^nd place

1chidb.com

low place

1cancernetwork.com

low place

amgen.com

wwwext.amgen.com

http://wwwext.amgen.com/media/media_pr_detail.jsp?year=2006&releaseID=837754

archive.org

Rathore AS, Winkle H (2009). "Quality by design for biopharmaceuticals". Nat. Biotechnol. 27 (1): 26–34. PMID 19131992. doi:10.1038/nbt0109-26.
Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. pp. 241, para os exemplod do infliximab, basiliximab, abciximab, daclizumab, palivusamab, gemtuzumab, alemtuzumab e rituximab, e o mecanismo e modo. ISBN 0-443-07145-4.

archive.today

"Dr. George Pieczenik". LMB Alumni. MRC Laboratory of Molecular Biology (LMB). 17 September 2009. Arquivado dende o orixinal o 23 de decembro de 2012. Consultado o 08 de febreiro de 2013.

bloomberg.com

http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aZWoVAXYGSgA

cam.ac.uk

www2.mrc-lmb.cam.ac.uk

"Dr. George Pieczenik". LMB Alumni. MRC Laboratory of Molecular Biology (LMB). 17 September 2009. Arquivado dende o orixinal o 23 de decembro de 2012. Consultado o 08 de febreiro de 2013.

cancernetwork.com

Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" Arquivado 15 de maio de 2009 en Wayback Machine. in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management Arquivado 05 de outubro de 2013 en Wayback Machine.

chidb.com

"Copia arquivada". Arquivado dende o orixinal o 08 de outubro de 2011. Consultado o 08 de febreiro de 2013.

doi.org

dx.doi.org

Riechmann L, Clark M, Waldmann H, Winter G (1988). "Reshaping human antibodies for therapy". Nature 332 (6162): 323–327. Bibcode:1988Natur.332..323R. PMID 3127726. doi:10.1038/332323a0.
Vlasek J, Ionescu R (2008). "Hetergeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods". Current Pharmaceutical Biotechnology 9 (6): 468–481. PMID 19075686. doi:10.2174/138920108786786402.
Beck A, Wurch T, Bailly C, Corvaia N (2010). "Strategies and challenges for the next generation of therapeutic antibodies". Nat. Rev. Immunol. 10 (5): 345–52. PMID 20414207. doi:10.1038/nri2747.
Khawli LA, Goswami S, Hutchinson R; et al. (2010). "Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats". MAbs 2 (6): 613–24. PMC 3011216. PMID 20818176. doi:10.4161/mabs.2.6.13333.
Zhang T, Bourret J, Cano T (2011). "Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography". J Chromatogr A 1218 (31): 5079–86. PMID 21700290. doi:10.1016/j.chroma.2011.05.061.
Rathore AS, Winkle H (2009). "Quality by design for biopharmaceuticals". Nat. Biotechnol. 27 (1): 26–34. PMID 19131992. doi:10.1038/nbt0109-26.
Schmitz U, Versmold A, Kaufmann P, Frank HG (2000). "Phage display: a molecular tool for the generation of antibodies—a review". Placenta 21 (Suppl A): S106–S112. PMID 10831134. doi:10.1053/plac.1999.0511.
Lonberg N, Huszar D (1995). "Human antibodies from transgenic mice". Int. Rev. Immunol. 13 (1): 65–93. PMID 7494109. doi:10.3109/08830189509061738.
Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991). "By-passing immunization. Human antibodies from V-gene libraries displayed on phage". J. Mol. Biol. 222 (3): 581–597. PMID 1748994. doi:10.1016/0022-2836(91)90498-U.
Carmen S, Jermutus L (2002). "Concepts in antibody phage display". Brief Funct Genomic Proteomic 1 (2): 189–203. PMID 15239904. doi:10.1093/bfgp/1.2.189.
Osbourn JK, Derbyshire EJ, Vaughan TJ, Field AW, Johnson KS (1998). "Pathfinder selection: in situ isolation of novel antibodies". Immunotechnology 3 (4): 293–302. PMID 9530562. doi:10.1016/S1380-2933(97)10007-0.
Modificado de Carter P (2001). "Improving the efficacy of antibody-based cancer therapies". Nat. Rev. Cancer 1 (2): 118–29. PMID 11905803. doi:10.1038/35101072.

elsevier.com

linkinghub.elsevier.com

Zhang T, Bourret J, Cano T (2011). "Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography". J Chromatogr A 1218 (31): 5079–86. PMID 21700290. doi:10.1016/j.chroma.2011.05.061.
Chadd HE, Chamow SM (2001). "Therapeutic antibody expression technology". Curr. Opin. Biotechnol. 12 (2): 188–94. PMID 11287236.
Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991). "By-passing immunization. Human antibodies from V-gene libraries displayed on phage". J. Mol. Biol. 222 (3): 581–597. PMID 1748994. doi:10.1016/0022-2836(91)90498-U.

harvard.edu

adsabs.harvard.edu

Riechmann L, Clark M, Waldmann H, Winter G (1988). "Reshaping human antibodies for therapy". Nature 332 (6162): 323–327. Bibcode:1988Natur.332..323R. PMID 3127726. doi:10.1038/332323a0.

kymab.com

"Copia arquivada". Arquivado dende o orixinal o 03 de febreiro de 2013. Consultado o 08 de febreiro de 2013.

landesbioscience.com

Khawli LA, Goswami S, Hutchinson R; et al. (2010). "Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats". MAbs 2 (6): 613–24. PMC 3011216. PMID 20818176. doi:10.4161/mabs.2.6.13333.

nih.gov

ncbi.nlm.nih.gov

Schwaber, J.; Cohen, E. P. (1973). "Human x mouse somatic cell hybrid clone secreting immunoglobulins of both parental types". Nature 244 (5416): 444–447. Bibcode 1973Natur.244..444S. doi:10.1038/244444a0. PMID 4200460.
Cambrosio, A.; Keating, P. (1992). "Between fact and technique: the beginnings of hybridoma technology". Journal of the History of Biology 25 (2): 175–230. doi:10.1007/BF00162840. PMID 11623041.
Köhler, G.; Milstein, C. (1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature 256 (5517): 495–497. Bibcode 1975Natur.256..495K. doi:10.1038/256495a0. PMID 1172191.
Riechmann L, Clark M, Waldmann H, Winter G (1988). "Reshaping human antibodies for therapy". Nature 332 (6162): 323–327. Bibcode:1988Natur.332..323R. PMID 3127726. doi:10.1038/332323a0.
Vlasek J, Ionescu R (2008). "Hetergeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods". Current Pharmaceutical Biotechnology 9 (6): 468–481. PMID 19075686. doi:10.2174/138920108786786402.
Beck A, Wurch T, Bailly C, Corvaia N (2010). "Strategies and challenges for the next generation of therapeutic antibodies". Nat. Rev. Immunol. 10 (5): 345–52. PMID 20414207. doi:10.1038/nri2747.
Khawli LA, Goswami S, Hutchinson R; et al. (2010). "Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats". MAbs 2 (6): 613–24. PMC 3011216. PMID 20818176. doi:10.4161/mabs.2.6.13333.
Zhang T, Bourret J, Cano T (2011). "Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography". J Chromatogr A 1218 (31): 5079–86. PMID 21700290. doi:10.1016/j.chroma.2011.05.061.
Rathore AS, Winkle H (2009). "Quality by design for biopharmaceuticals". Nat. Biotechnol. 27 (1): 26–34. PMID 19131992. doi:10.1038/nbt0109-26.
Siegel DL (2002). "Recombinant monoclonal antibody technology". Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 9 (1): 15–22. PMID 11889896.
Schmitz U, Versmold A, Kaufmann P, Frank HG (2000). "Phage display: a molecular tool for the generation of antibodies—a review". Placenta 21 (Suppl A): S106–S112. PMID 10831134. doi:10.1053/plac.1999.0511.
Klee GG. Human anti-mouse antibodies. Arch Pathol Lab Med. 2000 Jun;124(6):921-3. PMID 10835540. [1]
Chadd HE, Chamow SM (2001). "Therapeutic antibody expression technology". Curr. Opin. Biotechnol. 12 (2): 188–94. PMID 11287236.
Lonberg N, Huszar D (1995). "Human antibodies from transgenic mice". Int. Rev. Immunol. 13 (1): 65–93. PMID 7494109. doi:10.3109/08830189509061738.
McCafferty, J.; Griffiths, A.; Winter, G.; Chiswell, D. (1990). "Phage antibodies: filamentous phage displaying antibody variable domains". Nature 348 (6301): 552–554. Bibcode 1990Natur.348..552M. doi:10.1038/348552a0. PMID 2247164.
Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991). "By-passing immunization. Human antibodies from V-gene libraries displayed on phage". J. Mol. Biol. 222 (3): 581–597. PMID 1748994. doi:10.1016/0022-2836(91)90498-U.
Carmen S, Jermutus L (2002). "Concepts in antibody phage display". Brief Funct Genomic Proteomic 1 (2): 189–203. PMID 15239904. doi:10.1093/bfgp/1.2.189.
Osbourn JK (2002). "Proximity-guided (ProxiMol) antibody selection". Methods Mol. Biol. 178: 201–5. PMID 11968489.
Osbourn JK, Derbyshire EJ, Vaughan TJ, Field AW, Johnson KS (1998). "Pathfinder selection: in situ isolation of novel antibodies". Immunotechnology 3 (4): 293–302. PMID 9530562. doi:10.1016/S1380-2933(97)10007-0.
Modificado de Carter P (2001). "Improving the efficacy of antibody-based cancer therapies". Nat. Rev. Cancer 1 (2): 118–29. PMID 11905803. doi:10.1038/35101072.

oup.com

academic.oup.com

Carmen S, Jermutus L (2002). "Concepts in antibody phage display". Brief Funct Genomic Proteomic 1 (2): 189–203. PMID 15239904. doi:10.1093/bfgp/1.2.189.

regeneron.com

"Copia arquivada". Arquivado dende o orixinal o 29 de xuño de 2009. Consultado o 08 de febreiro de 2013.

sciencedirect.com

Osbourn JK, Derbyshire EJ, Vaughan TJ, Field AW, Johnson KS (1998). "Pathfinder selection: in situ isolation of novel antibodies". Immunotechnology 3 (4): 293–302. PMID 9530562. doi:10.1016/S1380-2933(97)10007-0.

ukbusinesspark.co.uk

"Copia arquivada". Arquivado dende o orixinal o 28 de setembro de 2011. Consultado o 08 de febreiro de 2013.

web.archive.org

"Copia arquivada". Arquivado dende o orixinal o 29 de xuño de 2009. Consultado o 08 de febreiro de 2013.
"Copia arquivada". Arquivado dende o orixinal o 03 de febreiro de 2013. Consultado o 08 de febreiro de 2013.
"Copia arquivada". Arquivado dende o orixinal o 28 de setembro de 2011. Consultado o 08 de febreiro de 2013.
"Copia arquivada". Arquivado dende o orixinal o 08 de outubro de 2011. Consultado o 08 de febreiro de 2013.
Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" Arquivado 15 de maio de 2009 en Wayback Machine. in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management Arquivado 05 de outubro de 2013 en Wayback Machine.

wikipedia.org

en.wikipedia.org

http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy